[1] TURPIN J A. The next generation of HIV/AIDS drugs： novel and developmental anti-HIV drugs and targets[J] . Expert Rev Anti Infect Ther，2003，1(1)：97-128. [2] DRUILLENNEC S，ROQUES B P. HIV-1 NCp7 as a target for the design of novel antiviral agents[J] . Drug News Perspect，2000，13(6)：337-349. [3] KANKIA B I，BARANY G，MUSIER-FORSYTH K. Unfolding of DNA quadruplexes induced by HIV-1 nucleocapsid protein[J] . Nucleic Acids Res，2005，33(14)：4395-4403. [4] MORELLET N，DE ROCQUIGNY H，MELY Y，et al. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H-NMR[J] . J Mol Biol，1994，235：287-301. [5] MARK-DANIELI M，LAHAM N，KENAN-EICHLER M，et al. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity[J] . J Virol，2005，9(12)：7756-7767. [6] EGELE C，SCHAUB E，RAMALANJAONA N，et al. HIV-1 nucleocapsid protein binds to the viral DNA initiation sequences and chaperones their kissing interactions[J] . J Mol Biol，2004，342 (2) ：453-466. [7] CAROLE B，SANDRINE J，DANIELA L. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance[J] . Int J Biochem Cell Biol，2004，36：1668-1686. [8] BOMBARDA E，CHERRADI H，MORELLET N. Zn2+ Binding properties of single-point mutants of the C-terminal zinc finger of the HIV-1 nucleocapsid protein：evidence of a critical role of cysteine 49 in Zn2+dissociation[J] . Biochemistry，2002，41：4312-4320. [9] HONG M K，HARBRON E J，O'CONNOR D B，et al. Nucleic acid conformational hanges essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer[J] . J Mol Biol，2003，325：1-10. [10] GOLINELLI M P，HUGHES S H. Self-priming of retroviral minus-strand strong-stop DNAs[J] . Virology，2001，285：278-290. [11] POLJAK L，BATSON S M，FICHEUX D，et al. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins[J] . J Mol Biol，2003，329： 411-421. [12] BUCKMAN J S，BOSCHE W J，GORELICK R J. Human immunodeficiency virus Type 1 nucleocapsid Zn2+ fingers are required for efficient reverse transcription，initial integration processes，and protection of newly synthesized viral DNA[J] . J Virol，2003，77： 1469-1480. [13] ERIK DE C. Novel compounds in preclinical/early clinical development for the treatment of HIV infections[J] . Rev Med Virol，2000，10：255-277. [14] ZHAO Q，EMST J T，HAMILTON A D，et al. XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41[J] . AIDS Res Hum Retroviruses，2002，18(14)：989-997. [15] HUANG M J，ANDREW M，JIM A，et al. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins[J] . J Med Chem，1998，41：1371-1381. [16] JENKINS L M，BYRD J C，HARA T，et al. Studies on the mechanism of inactivation of the HIV-1 nucleocapsid proteinNCp7 with 2-mercaptobenzamide thioesters[J] . J Med Chem，2005，48，2847-2858. [17] GOEBEL F D，HEMMER R，SCHMIT J C，et al. Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy[J] . AIDS，2001，15(1)：33-45. [18] ERIK DE C. New developments in anti-HIV chemotherapy[J] . Farmaco，2001，(56)：3-12. [19] VENKATESHA B，SONG Y S，SHARLYN J，et al. Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters[J] . J Biol Chem，2000，275(20)：14890-14897. [20] JIM A，TURPIN，SONG Y S，et al. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers [J] . J Med Chem，1999 14;42(1)：67-86. [21] SONG Y S，ATUL G，VENKATESHA B，et al. Synthesis and biological properties of amino acid amide ligand-based pyridinioalkanoyl thioesters as anti-HIV agents[J] . Bioorg Med Chem，2002，10(5)：1263-1273. [22] WONDRAK E M，SAKAGUCHI K，RICE W G，et al. Removal of zinc Is required for processing of the mature nucleocapsid protein of human immunodeficiency virus，type 1，by the viral protease[J] . J Biol Chem，1994，269(35)：21948-21950.